A. Hansen Ree, G. M. Mælandsmo, K. Flatmark, H. G. Russnes, M. Gómez Castañeda, and E. Aas, “Cost-effectiveness of molecularly matched off-label therapies for end-stage cancer – the MetAction precision medicine study”, AO, vol. 61, no. 8, pp. 955–962, Aug. 2022.